1842
N. K. Gusarova et al. / Tetrahedron Letters 51 (2010) 1840–1843
10. Artem’ev, A. V.; Malyisheva, S. F.; Gusarova, N. K.; Trofimov, B. A. Russ. J. Org.
Chem. 2009, in press.
11. Experimental procedure: Amorphous grey selenium (0.158 g, 2 mmol) was
added to a solution of phosphine 2 (1.1 mmol) in EtOH (5 mL) at 70 °C under
argon. Lupinine 1a (0.169 g, 1 mmol) or anabasine 1b (0.162 g, 1 mmol) in
EtOH (2 mL) was added to the stirred suspension which was stirred until
complete dissolution of selenium (ca. 1–1.5 h) at 70 °C; this gave a colorless,
transparent soln. The solvent was removed under reduced pressure and the
residue was washed with cold Et2O (6 mL ꢃ 1) and dried in vacuo (1 Torr, rt) to
give salts 3.
Compound 3a: (1R,9aR)-1-(hydroxymethyl)octahydro-2H-quinolizinium bis(2-
phenylethyl)diselenophosphinate: colorless crystalline powder, yield 0.518 g
(91%), mp 164–167 °C (EtOH), ½a 2D1 /cmꢁ1): 3335,
ꢁ19.1 (c 2.0, EtOH). IR (KBr, m
ꢀ
3083, 3061, 2943, 2865, 2838, 2727, 1601, 1583, 1496, 1451, 1432, 1425, 1408,
1396, 1378, 1362, 1348, 1334, 1314, 1298, 1270, 1260, 1212, 1198, 1188, 1158,
1124, 1106, 1076, 1056, 1047, 1024, 1013, 986, 968, 946, 930, 906, 894, 877,
859, 834, 825, 808, 764, 751, 735, 713, 695, 596, 579, 509, 481, 382. 1H NMR
(400.13 MHz, CDCl3, ppm), d: 1.15–1.25 (m, 1H, H-C8), 1.61–1.93 (m, 10H, H-
C
2,3,4ax,7–9), 2.20–2.53 (m, 1H, H-C6ax), 2.55–2.62 (m, 4H, CH2P), 2.68–2.73 (m,
1H, H-C1), 2.90–2.97 (m, 1H, H-C9a), 3.11–3.17 (m, 4H, CH2Ph), 3.35–3.40 (m,
1H, H-C6eq), 3.50–3.70 (m, 1H, H-C4eq), 3.78–4.16 (m, 2H, CH2OH), 7.16–7.37
(m, 10H, Ph), 9.50 (s, 2H, NH, OH). 13C NMR (100.62 MHz, CDCl3, ppm), d: 17.77
and 18.53 (C-3), 19.92 and 20.49 (C-8), 22.46 and 22.85 (C-7), 23.19 and 23.50
(C-9), 28.03 and 28.75 (C-2), 31.27 (CH2Ph), 37.27 and 40.07 (C-1), 44.53 (d,
1JP,C = 36.4 Hz, CH2P), 45.65 and 53.53 (C-6), 56.61 and 57.20 (C-4), 59.45 (C-
10), 62.05 (C-9a), 62.85 (C-10), 67.27 (C-9a), 126.10 (C-p in Ph), 128.63, 128.69
(C-o,m in Ph), 142.17 (d, 3JP,C = 17.2 Hz, C-i in Ph). 31P NMR (161.98 MHz, CDCl3,
ppm), d: 25.13 (satellites 1JP,Se = 573 Hz). 77Se NMR (76.31 MHz, CDCl3, ppm), d:
1
ꢁ59.40 (d, JP,Se = 573 Hz). Calcd for C26H38NOPSe2 (%): C, 54.84; H, 6.73; N,
2.46; P, 5.44; Se, 27.73. Found (%): C, 54.90; H, 6.76; N, 2.40; P, 5.38; Se, 27.70.
In the 13C NMR spectra of salts 3a,b, the presence of two signals for all the
carbon atoms in the lupinine unit is due to the equilibrium (in solution)
between two protonated forms of this alkaloid (s-cis and s-trans), which differ
in the spatial location of the proton conjugated with nitrogen atom. Similar
duplication of signals in the 13C NMR spectra of known salts of lupinine (for
example, in the 13C NMR spectrum of lupinine hydrochloride) has been
reported.20
Figure 2. Packing diagram of the structure of 3a.
In conclusion, a three-component reaction between secondary
phosphines, elemental selenium, and natural lupinine or anabasine
has been shown to be a convenient one-pot, atom-economic route
to optically active diselenophosphinates of alkaloids, as potential
drug candidates and/or precursors for the synthesis of pharmaceu-
tically important compounds.
Compound 3b: (1R,9aR)-1-(hydroxymethyl)octahydro-2H-quinolizinium bis[2-
(2-furyl)ethyl]diselenophos-phinate: colorless crystalline powder, yield 0.489 g
(89%), mp 90–92 °C (EtOH), ½a 2D1 /cmꢁ1): 3332,
ꢁ9.6 (c 2.0, EtOH). IR (KBr, m
ꢀ
2927, 2889, 2855, 2720, 2700, 2653, 2590, 1727, 1656, 1638, 1628, 1588, 1543,
1506, 1472, 1448, 1410, 1371, 1357, 1338, 1330, 1312, 1282, 1265, 1230, 1218,
1166, 1147, 1128, 1105, 1074, 1059, 1048, 1024, 1008, 969, 947, 932, 910, 883,
858, 844, 825, 807, 793, 756, 743, 732, 696, 678, 598, 584, 548, 499, 478, 455.
1H NMR (400.13 MHz, CDCl3, ppm), d: 1.15–1.25 (m, 1H, H-C8), 1.40–2.08 (m,
10H, H-C2,3,4ax,7–9), 2.16–2.40 (m, 1H, H-C6ax), 2.51–2.60 (m, 4H, CH2P), 2.61–
2.69 (m, 1H, H-C1), 2.98–3.06 (m, 1H, H-C9a), 3.10–3.16 (m, 4H, CH2Fur), 3.25–
3.50 (m, 1H, H-C6eq), 3.60–3.75 (m, 1H, H-C4eq), 3.78–4.10 (m, 2H, CH2OH),
6.01–6.02 (m, 2H, H-C2 in Fur), 6.25–6.26 (m, 2H, H-C3 in Fur), 7.28–7.29 (m,
2H, H-C4 in Fur), 9.30 (s, 2H, NH, OH). 13C NMR (100.62 MHz, CDCl3, ppm), d:
17.35 and 18.13 (C-3), 19.50 and 20.06 (C-8), 22.04 and 22.43 (C-7), 22.73 and
23.12 (C-9), 23.68 (CH2 Fur), 27.65 and 28.23 (C-2), 36.62 and 39.72 (C-1),
Acknowledgments
This work was supported by the President of the Russian Feder-
ation (program for the support of leading scientific schools, Grant
No. NSh-263.2008.3) and the Russian Foundation for Basic Re-
search (project No. 08-03-00251).
1
40.30 (d, JP,C = 38.1 Hz, CH2P), 45.78 and 53.13 (C-6), 56.15 and 56.71 (C-4),
59.08 (C-10), 61.73 (C-9a), 62.35 (C-10), 66.78 (C-9a), 104.76 (C-2 in Fur),
3
109.99 (C-3 in Fur), 140.70 (C-4 in Fur), 155.10 (d, JP,C = 20.3 Hz, C-1 in Fur).
References and notes
1
31P NMR (161.98 MHz, CDCl3, ppm), d: 23.60 (satellites JP,Se = 581 Hz). 77Se
1
NMR (76.31 MHz, CDCl3, ppm), d: ꢁ60.10 (d, JP,Se = 581 Hz). Calcd for
1. (a) Marion, L. The Alkaloids, R. H. F. Manske (Ed.), New York, 1950; (b) Robins, D.
J. In The Alkaloids, Chemistry and Pharmacology; Cordell, G., Ed.; Academic Press:
San Diego, 1995; pp 1–57; (c) Mizrachi, N.; Levy, S.; Goren, Z. J. Forensic Sci.
2000, 45, 736; (d) Steenkamp, P. A.; Heerden, F. R.; Wyk, B. E. J. Forensic Sci.
2002, 127, 208.
C22H34NO3PSe2 (%): C, 48.09; H, 6.24; N, 2.55; P, 5.64; Se, 28.74. Found (%):
C, 48.11; H, 6.26; N, 2.56; P, 5.50; Se, 28.63.
Compound 3c: (S)-2-(pyridin-3-yl)piperidinium bis(2-phenylethyl)diseleno-
phosphinate: colorless oil, yield: 0.529 g (94%), ½a D21
ꢁ4.9 (c 2.0, EtOH). IR (film,
ꢀ
m
/cmꢁ1): 3354, 3083, 3025, 2922, 2851, 2352, 2197, 1951, 1881, 1811, 1751,
2. (a) Daly, J. W.; Carraffo, H. M.; Spande, T. F. In Alkaloids: Chemical and Biological
Perspectives; Pelletier, S. W., Ed.; Wiley: New York, 1999; Vol. 13, p 1; (b)
Michael, J. P. In The Alkaloids, Chemistry and Pharmacology; Cordell, G., Ed.;
Academic Press: New York, 2001; pp 91–258; (c) Michael, J. P. Nat. Prod. Rep.
2008, 25, 139–187.
3. (a) Navashin, S. M.; Fomina, I. P. Rational Therapy with Antibiotics (A Handbook);
Meditsina: Moscow, 1983 (in Russian); (b) Abdulina, G. A.; Gazaliev, A. M.;
Baikenova, G. G. Khim.-Farm. Zh. 2002, 36, 11.
4. (a) Mashkovsky, M. D. In Lekarstvennye sredstva [Pharmaceuticals]; Novaya
volna: Moscow, Russia, 2000; Vol. 1 (in Russian); (b) Jacob, P.; Hatsukami, D.;
Severson, H.; Hall, S.; Yu, L.; Benowitz, N. L. Cancer Epidemiology, Biomarkers
Prevention 2002, 11, 1668.
5. (a) Roark, R. C. Ind. Eng. Chem. 1935, 27, 530; (b) Klyshev, A. K. The Biology of
Anabasis aphylla L. Izd. Akad. Nauk Kaz. SSR: Alma-Ata, 1961 (in Russian).
6. Gafurova, Sh. M.; Abduvakhabov, A. A.; Aslanov, Kh. A. Uzb. Khim. Zhurn. 1979,
56.
7. Aimakov, O. Ph.D. Thesis, Moscow, 2002.
8. Tilyabaev, Z.; Baimirzaev, S. S.; Kushiev, Kh. Kh.; Dalimov, D. N.; Gafurov, M. B.
Chem. Nat. Compd. 1994, 30, 57.
9. (a) Parker, J. N.; Parker, P. M. Selenium: A Medical Dictionary, Bibliography, and
Annotated Research Guide to Internet References; ICON Group International: San
Diego, 2004; (b) Reilly, C. Selenium in Food and Health; Springer: New York,
2006.
1602, 1581, 1496, 1454, 1434, 1326, 1298, 1280, 1263, 1206, 1193, 1153, 1126,
1102, 1077, 1049, 1029, 944, 910, 835, 807, 757, 663, 643, 631, 618, 574, 507, 478,
444. 1H NMR (400.13 MHz, CDCl3, ppm), d: 1.75–2.05 (m, 6H, H-C3–5), 2.03–2.37
(m, 4H, CH2P), 2.83–2.90 (m, 4H, CH2Ph), 3.02 (ddd, 1H, 2J = 12.8 Hz, 3J = 9.6 Hz,
3J = 2.9 Hz, HaxC6), 3.67 (d, 1H, 2J = 12.8 Hz, HeqC6), 4.22 (d, 1H, 3J = 10.5 Hz,
HaxC2), 7.05–7.15 (m, 11H in Ph, H-C5 in Py), 8.13 (d, 1H, 3J = 8.2 Hz, H-C4 in Py),
8.29 (d, 1H, 3J = 4.7 Hz, H-C6 in Py), 8.69 (s, 1H, H-C2 in Py), 9.08 (s, 2H, NH). 13
C
NMR (100.62 MHz, CDCl3, ppm), d: 22.35 (C-4), 23.05 (C-5), 30.85 (CH2Ph, C-3),
44.79 (d, 1JP,C = 36.5 Hz, CH2P), 45.52(C-6), 58.63(C-2), 124.06 (C-5 inPy), 125.94
(C-p in Ph), 128.38 (C-o in Ph), 128.41 (C-m in Ph), 133.12 (C-3 in Py), 136.34 (C-4
in Py), 141.61 (d, 3JP,C = 17.2 Hz, C-i in Ph), 148.92 (C-2 in Py), 149.86 (C-6 in Py).
31P NMR (161.98 MHz, CDCl3, ppm), d: 25.49 (satellites 1JP,Se = 573 Hz). 77Se NMR
(76.31 MHz, CDCl3, ppm), d: ꢁ68.56 (d, 1JP,Se = 573 Hz). Calcd for C26H33N2PSe2
(%): C, 55.52; H, 5.91; N, 4.98; P, 5.51; Se, 28.08. Found (%): C, 55.58; H, 6.00; N,
4.94; P, 5.39; Se, 28.04.
Compound 3d: (S)-2-(pyridin-3-yl)piperidinium bis[2-(4-tertbutylphenyl)ethyl] -
diselenophosphinate: colorless oil, yield: 0.614 g (91%), ½a D21
ꢁ4.1 (c 2.0, EtOH). IR
ꢀ
(film, m
/cmꢁ1): 3443, 2959, 2904, 2864, 2804, 2774, 2705, 1633, 1596, 1577,
1516, 1463, 1444, 1432, 1416, 1363, 1326, 1294, 1268, 1201, 1132, 1108, 1077,
1048, 1017, 1008, 941, 910, 875, 853, 838, 812, 769, 730, 710, 661, 631, 616, 563,
526, 493, 443. 1H NMR (400.13 MHz, CDCl3, ppm), d: 1.28 (s, 18H, Me), 1.90–2.15
(m, 6H, H-C3–5), 2.39–2.45 (m, 4H, CH2P), 2.90–2.96 (m, 4H, CH2Ph), 3.10 (t, 1H,
2J = 11.2 Hz, HaxC6), 3.84 (d, 1H, 2J = 11.2 Hz, HeqC6), 4.27 (d, 1H, 3J = 12.0 Hz,